0 Comentários
0 Compartilhamentos
772 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
The Impact of Hormonal Therapy vs. Non-Hormonal Approaches in the Gynecology Drug SectorThe distinction between Hormonal Therapy and non-hormonal approaches is a central feature of the women's health drug sector. Hormonal agents, including oral contraceptives and hormone replacement therapies (HRT), command the largest share of the therapeutic space due to decades of established efficacy in managing a wide range of conditions, from menstrual disorders to postmenopausal symptoms....0 Comentários 0 Compartilhamentos 614 Visualizações 0 Anterior
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Comentários 0 Compartilhamentos 52 Visualizações 0 Anterior
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Comentários 0 Compartilhamentos 5 Visualizações 0 Anterior
-
Global Superficial X-Ray Therapy System Market Growing at 4.7% CAGRAccording to a new report from Intel Market Research, the global Superficial X-Ray Therapy System market was valued at USD 312.5 million in 2025 and is projected to reach USD 472.8 million by 2034, growing at a CAGR of 4.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-melanoma skin cancers, increasing patient preference for...0 Comentários 0 Compartilhamentos 2 Visualizações 0 Anterior